DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Reliance Chemotex Industries Limited — Outcome of Board Meeting

NSE 3 hrs ago·11 Aug 2026, 7:13 am

Company NSE

Reliance Chemotex Industries Limited has informed the stock exchange about its financial results for the period ending June 30, 2026. This announcement follows the company's scheduled board meeting and confirms the submission of the necessary documents to the market regulator.

For investors, this update is a standard procedural step that ensures the company's financial performance is officially recorded and available for public review. It provides a baseline for tracking the company's operational health and financial trajectory.

Investors should look for the detailed financial statements to assess the company's profitability, cash flow, and overall performance against previous periods. Keeping an eye on the specific figures will help in evaluating the company's current standing.